CFO David Lowrance sells 394,528 shares of SVRA at $5.68 for $2.2M; retains 536,032 shares plus 233,750 in options.
David L Lowrance, Chief Financial Officer of Savara Inc, sold 394,528 shares at $5.68 on 2026-06-22 for $2,241,431.93, reducing his non-derivative holdings from 930,560 to 536,032 shares. The company is unprofitable with net income of $-37,284,000.00 (latest full fiscal year) and zero revenue in the most recent quarter, yet carries a market cap of $1,166,035,836.28. Lowrance maintains significant derivative holdings of 233,750 shares via options across six separate awards, indicating his overall stake remains material. The sale occurred while the stock trades at $5.69, near the 52-week high of $7.00 but up 13.4% over the prior 30 days and 12.9% over 90 days—a period of positive momentum. This partial reduction of non-derivative holdings by a CFO of a loss-making biotech warrants monitoring for any accompanying disclosures about funding, operations, or capital strategy shifts.